NO20043243L - Legemiddelleveringssystem for vedvarende frigivelse av glipizid - Google Patents

Legemiddelleveringssystem for vedvarende frigivelse av glipizid

Info

Publication number
NO20043243L
NO20043243L NO20043243A NO20043243A NO20043243L NO 20043243 L NO20043243 L NO 20043243L NO 20043243 A NO20043243 A NO 20043243A NO 20043243 A NO20043243 A NO 20043243A NO 20043243 L NO20043243 L NO 20043243L
Authority
NO
Norway
Prior art keywords
glipizide
delivery system
drug delivery
sustained release
sustained
Prior art date
Application number
NO20043243A
Other languages
English (en)
Norwegian (no)
Inventor
Charles Chiao
Original Assignee
Ivax Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Research Inc filed Critical Ivax Research Inc
Publication of NO20043243L publication Critical patent/NO20043243L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20043243A 2002-01-04 2004-08-02 Legemiddelleveringssystem for vedvarende frigivelse av glipizid NO20043243L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34526702P 2002-01-04 2002-01-04
PCT/US2003/000160 WO2003057278A2 (fr) 2002-01-04 2003-01-04 Systeme d'apport de medicament destine a l'apport continu de glipizide

Publications (1)

Publication Number Publication Date
NO20043243L true NO20043243L (no) 2004-08-02

Family

ID=23354287

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043243A NO20043243L (no) 2002-01-04 2004-08-02 Legemiddelleveringssystem for vedvarende frigivelse av glipizid

Country Status (12)

Country Link
US (1) US20030224050A1 (fr)
EP (1) EP1575639A2 (fr)
JP (1) JP2005525311A (fr)
KR (1) KR20040081446A (fr)
CN (1) CN101410091A (fr)
AU (1) AU2003202879A1 (fr)
CA (1) CA2471211A1 (fr)
MX (1) MXPA04006522A (fr)
NO (1) NO20043243L (fr)
PL (1) PL377117A1 (fr)
RU (1) RU2004123792A (fr)
WO (1) WO2003057278A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US8679533B2 (en) 2002-07-25 2014-03-25 Pharmacia Corporation Pramipexole once-daily dosage form
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
BRPI0614021A2 (pt) * 2005-01-21 2011-03-01 Pharmanova Inc formulações farmacêuticas e métodos de uso
PL204780B1 (pl) * 2006-06-02 2010-02-26 Zak & Lstrok Ady Farmaceutyczn Tabletka powlekana o przedłużonym uwalnianiu substancji aktywnej otrzymywana metodą bezpośredniego tabletkowania zawierająca indapamid albo jego farmaceutyczną sól oraz farmaceutycznie dopuszczalne wypełniacze, zastosowanie karbomeru do wytwarzania tabletki oraz sposób jej powlekania
KR101152977B1 (ko) * 2009-12-14 2012-06-11 근화제약주식회사 약제학적 제제
CN103211787B (zh) * 2012-01-18 2017-06-06 北京天衡医院管理有限公司 格列吡嗪膜控缓释微丸胶囊
US10751287B2 (en) * 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
CN104666280B (zh) * 2015-03-21 2017-10-13 合肥华方医药科技有限公司 一种格列吡嗪口腔速溶膜及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US5130242A (en) * 1988-09-07 1992-07-14 Phycotech, Inc. Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
US6048547A (en) * 1996-04-15 2000-04-11 Seth; Pawan Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient
US5885616A (en) * 1997-08-18 1999-03-23 Impax Pharmaceuticals, Inc. Sustained release drug delivery system suitable for oral administration
NZ506202A (en) * 1998-03-19 2003-10-31 Bristol Myers Squibb Co Biphasic controlled release delivery system for high solubility pharmaceuticals and method

Also Published As

Publication number Publication date
AU2003202879A1 (en) 2003-07-24
MXPA04006522A (es) 2004-10-04
JP2005525311A (ja) 2005-08-25
US20030224050A1 (en) 2003-12-04
CN101410091A (zh) 2009-04-15
CA2471211A1 (fr) 2003-07-17
WO2003057278A2 (fr) 2003-07-17
RU2004123792A (ru) 2005-04-10
EP1575639A2 (fr) 2005-09-21
WO2003057278A3 (fr) 2013-12-19
KR20040081446A (ko) 2004-09-21
PL377117A1 (pl) 2006-01-23

Similar Documents

Publication Publication Date Title
DK1545662T3 (da) Lægemiddelindgivelsessystem
NO20041315L (no) Medikamentavleveringssystem
DK1530965T3 (da) Kontrolleret frigivelsesleveringssystem til nasal applikation
DK1635875T3 (da) In-situ-geldannende lægemiddeladministrationssystem
ATE536861T1 (de) Bioerodierbare arzneimittelabgabesysteme mit verzögerter freisetzung
ATE405630T1 (de) Wirkstoffabgabesysteme
IL158527A0 (en) Sustained release drug delivery system containing codrugs
DK1545467T3 (da) Faste farmaceutiske formuleringer omfattende telmisartan
PL1631255T3 (pl) System dostarczania leków
DK1599186T3 (da) System til administration af transmukalt lægemiddel
AU2003221770A8 (en) Controlled release transdermal drug delivery
PL376169A1 (en) Drug delivery system
IL159273A0 (en) Transdermal delivery system for sustained release of polypeptides
IL174396A0 (en) Oral drug delivery system
EP1490029A4 (fr) Systeme d'administration de medicaments a liberation controlee de pravastatine
NO20043243L (no) Legemiddelleveringssystem for vedvarende frigivelse av glipizid
EP1503739A4 (fr) Liberation reguliere de medicaments combines de guaifenesin
ATE327759T1 (de) Pharmazeutische zusammensetzung mit verlungerter freisetzung
DE60225154D1 (de) Neues selbstemulgierendes arzneimittelfreisetzungssystem
NO20043576L (no) Pharmaceutical formulation comprising melatonin
DE60321572D1 (de) Transdermales arzneimittelverabreichungssystem
NO20043633L (no) Oral doseringsform for kontrollert medikamentfrigivning
ITMI20020921A0 (it) Dispositivo per la sommistrazione di farmaci
EP1620077A4 (fr) Systeme d'administration de medicament par voie orale presentant une liberation prolongee amelioree
SI1635787T1 (sl) Bioeredibilni sistemi za oddajanje zdravil z zadrževanim sproščanjem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application